ANGIOTENSIN AT2 RECEPTOR STIMULATION OR AT1 RECEPTOR BLOCKADE ACT ANTI-INFLAMMATORY AND ANTI-FIBROTIC IN A MOUSE MODEL OF SCLERODERMA

被引:0
|
作者
Rompe, F. [1 ]
Santi, F. [1 ]
Stroeder, K. [1 ]
Wieland, A. [1 ]
Artuc, M. [2 ]
Thoene-Reineke, C. [1 ]
Unger, T. [1 ]
Steckelings, U. M. [1 ]
机构
[1] Charite Univ Med Berlin, Dept Pharmacol, Cardiovasc Res Ctr, Berlin, Germany
[2] Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:1165 / 1165
页数:1
相关论文
共 50 条
  • [1] ANGIOTENSIN AT2 RECEPTOR STIMULATION OR AT1 RECEPTOR BLOCKADE ACT ANTI-INFLAMMATORY AND ANTI-FIBROTIC IN A MOUSE MODEL OF SCLERODERMA
    Santi, F.
    Wieland, A.
    Stroeder, K.
    Rompe, F.
    Reichenbach, A.
    Artuc, M.
    Thoene-Reineke, C.
    Unger, T.
    Steckelings, U. M.
    JOURNAL OF HYPERTENSION, 2009, 27 : S311 - S311
  • [2] Angiotensin AT2 receptor stimulation or AT1 receptor blockade act anti-inflammatory and anti-fibrotic in a mouse model of scleroderma
    Santi, F.
    Stroeder, K.
    Rompe, F.
    Wieland, A.
    Artuc, M.
    Thoene-Reineke, C.
    Unger, T.
    Steckelings, U. M.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (03) : 278 - 278
  • [3] Direct angiotensin AT2 receptor stimulation by the novel non-peptide agonist Compound 21 acts anti-inflammatory and anti-fibrotic in a mouse model of scleroderma
    Stroeder, K.
    Rompe, F.
    Reichenbach, A.
    Thoene-Reineke, C.
    Artuc, M.
    Hallberg, A.
    Alterman, M.
    Unger, T.
    Steckelings, U. M.
    JOURNAL OF HYPERTENSION, 2008, 26 : S369 - S369
  • [4] ANGIOTENSIN (1-7) EVOKES AT2 RECEPTOR-MEDIATED ANTI-FIBROTIC EFFECTS IN THE PRESENCE OF AT1 RECEPTOR BLOCKADE
    Phua, D. S.
    Widdop, R. E.
    Jones, E. S.
    HYPERTENSION, 2008, 52 (01) : 174 - 174
  • [5] Anti-fibrotic mechanisms of angiotensin AT2-receptor stimulation
    Sumners, Colin
    Peluso, Antonio Augusto
    Haugaard, Andreas Houe
    Bertelsen, Jesper Bork
    Steckelings, Ulrike Muscha
    ACTA PHYSIOLOGICA, 2019, 227 (01)
  • [6] Anti-fibrotic Potential of AT2 Receptor Agonists
    Wang, Yan
    Del Borgo, Mark
    Lee, Huey W.
    Baraldi, Dhaniel
    Hirmiz, Baydaa
    Gaspari, Tracey A.
    Denton, Kate M.
    Aguilar, Marie-Isabel
    Samuel, Chrishan S.
    Widdop, Robert E.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [7] CHRONIC AT2 RECEPTOR STIMULATION IS ANTI-FIBROTIC IN AORTIC BANDED MICE
    Tan, D. S.
    Kaufman, S. F.
    Jones, E. S.
    Widdop, R. E.
    HYPERTENSION, 2011, 58 (01) : 121 - 121
  • [8] Anti-fibrotic and Anti-inflammatory Roles of Caveolin-1 in Scleroderma
    Tourkina, E. V.
    Richard, M.
    Bonner, M.
    Silver, R. M.
    Hoffman, S.
    MOLECULAR BIOLOGY OF THE CELL, 2006, 17
  • [9] AT2 RECEPTOR STIMULATION AND AT1 RECEPTOR BLOCKADE ACT ANTI-APOPTOTIC AND TISSUE-PROTECTIVE IN EXPERIMENTAL DIABETIC RETINOPATHY
    Steckelings, U. M.
    Stroeder, K.
    Reichenbach, A.
    Horlbeck, M.
    Kummert, M.
    Rompe, F.
    Schwengel, K.
    Namsolleck, P.
    Thoene-Reineke, C.
    Unger, T.
    JOURNAL OF HYPERTENSION, 2009, 27 : S312 - S312
  • [10] Celastrol is a novel selective agonist of cannabinoid receptor 2 with anti-inflammatory and anti-fibrotic activity in a mouse model of systemic sclerosis
    Jiang, Xingwu
    Chen, Si
    Zhang, Qiansen
    Yi, Chunyang
    He, Jiacheng
    Ye, Xiyun
    Liu, Mingyao
    Lu, Weiqiang
    PHYTOMEDICINE, 2020, 67